NLC Florida Healthcare Sciences DST

Other real estate
Rule 506(b)
Nashua, New Hampshire
Amended Oct 8, 2026

Raising: $97,038,429
Sold so far: $45,907,278; 47% sold
Investors: 24
Average check: $1,912,803; Sold ÷ investors
Minimum: $150,000
Sales commissions: $410,634; Issuer's estimate

In plain English

NLC Florida Healthcare Sciences DST, a real estate business based in Nashua, New Hampshire, filed an amended Form D with the SEC on Oct 8, 2026 to raise about $97 million. It reports about $45.9 million raised from 24 investors, 47% of its target. That works out to roughly $1,913,000 per investor. The smallest investment it accepts from an outside investor is $150,000.

It filed under Rule 506(b), which means the offering can't be advertised to the public. Investors in these deals usually already have a relationship with the sponsor.

How it compares

Against the 594 real estate offerings filed Oct 6 – Nov 4, 2026.

This offeringMedian

Raise size$97M vs $7.7M median

Larger than 90% of the 460 offerings that set a size.

How much is sold47% sold vs 50% median

Behind 51% of the 460 offerings with a set size.

Minimum investment$150,000 vs $50,000 median

Higher than 79% of the 427 offerings that stated a minimum.

Where the sponsor is based

The New Hampshire housing market

Typical home value $511KChange, 12 months 2.9%

Form D lists the issuer's principal place of business, not where its properties are. Home values for Sep 2026.

See New Hampshire market data

Filing details

File number: 021-595269
Latest filing: Form D/A (amendment), Oct 8, 2026
Accession number: 0000932440-26-000036
Entity type: Delaware Statutory Trust
Industry group: Other Real Estate
Principal place of business: Nashua, New Hampshire
Exemption claimed: Rule 506(b)
First sale: Sep 1, 2026

Timeline

First sale
Sep 1, 2026
Latest amendment (Form D/A) filed
Oct 8, 2026
$45.9M sold (47% of the target)
As reported Oct 8, 2026

Other recent filings from New Hampshire

All fund filings

NLC Phoenix EVS Corp HQ DSTNashua · Other real estate · 506(b) · Nov 3$214M

This page summarizes a notice NLC Florida Healthcare Sciences DST filed with the SEC. Fidelis First is not affiliated with NLC Florida Healthcare Sciences DST, has not reviewed this offering and does not recommend it. Nothing here is an offer to sell or a solicitation of an offer to buy any security. Figures are as the issuer reported them on Oct 8, 2026 and may have changed since.

Sales commissions are the issuer's estimate for the whole offering, not amounts paid so far. Average check is derived: amount sold divided by number of investors. Issuers don't have to amend a Form D when sales or investor counts change, so these can lag.

Source: SEC EDGAR, Form D · As of Oct 8, 2026

Source: Data Provided by Zillow Group · As of Sep 2026